Patents by Inventor Ian Comerford

Ian Comerford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND PRODUCTS FOR PREVENTING AND/OR TREATING METASTATIC CANCER
    Publication number: 20180022818
    Abstract: The present invention provides a catalyst precursor and a catalyst suitable for preparing multi-wall carbon nanotubes. The resulting multi-wall carbon nanotubes have a narrow distribution as to the number of walls forming the tubes and a narrow distribution in the range of diameters for the tubes. Additionally, the present invention provides methods for producing multi-wall carbon nanotubes having narrow distributions in the number of walls and diameters. Further, the present invention provides a composition of spent catalyst carrying multi-wall nanotubes having narrow distribution ranges of walls and diameters.
    Type: Application
    Filed: July 21, 2017
    Publication date: January 25, 2018
    Applicant: Adelaide Research & Innovation Pty Ltd
    Inventors: Shaun Reuss McColl, Ian Comerford, Yuka Harata-Lee, Mark Smyth
  • Methods and products for preventing and/or treating metastatic cancer
    Patent number: 9718887
    Abstract: The present disclosure relates to the prevention and/or treatment of metastatic cancer. Certain example embodiments of the present disclosure provide a method for preventing and/or treating a metastatic cancer in a subject. The method comprises administering to the subject a therapeutically effective amount of an inhibitor of a chemokine receptor CCX-CKR.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: August 1, 2017
    Assignees: Adelaide Research & Innovation PTY LTD, Peter Maccallum Cancer Institute
    Inventors: Shaun Reuss Mccoll, Ian Comerford, Yuka Harata-Lee, Mark Smyth
  • Methods and Products for Preventing and/or Treating Metastatic Cancer
    Publication number: 20150291698
    Abstract: The present disclosure relates to the prevention and/or treatment of metastatic cancer. Certain example embodiments of the present disclosure provide a method for preventing and/or treating a metastatic cancer in a subject. The method comprises administering to the subject a therapeutically effective amount of an inhibitor of a chemokine receptor CCX-CKR.
    Type: Application
    Filed: September 6, 2013
    Publication date: October 15, 2015
    Applicants: Peter MacCallum Cancer Institute, Adelaide Research & Innovation Pty Ltd
    Inventors: Shaun Reuss Mccoll, Ian Comerford, Yuka Harata-Lee, Mark Smyth